Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kotaro Shirakawa

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 3, 2025
[Recent advances in research of cure of HIV infection]Kotaro Shirakawa
Mini Reviews in Medicinal Chemistry|March 14, 2008
Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapyTaisuke Izumi, Kotaro Shirakawa, Akifumi Takaori-Kondo
Current Opinion in HIV and AIDS|January 19, 2011
Epigenetic regulation of HIV latencyShweta Hakre, Leonard Chavez, Kotaro Shirakawa, et al.
FEMS Microbiology Reviews|March 1, 2012
HIV latency: experimental systems and molecular modelsShweta Hakre, Leonard Chavez, Kotaro Shirakawa, et al.
Trends in Microbiology|March 23, 2013
Reactivation of latent HIV by histone deacetylase inhibitorsKotaro Shirakawa, Leonard Chavez, Shweta Hakre, et al.
Biochemical and Biophysical Research Communications|May 25, 2020
Critical role of PP2A-B56 family protein degradation in HIV-1 Vif mediated G2 cell cycle arrestKayoko Nagata, Keisuke Shindo, Yusuke Matsui, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2004
[Analyses of the allogeneic stem cell transplantation outcome based on the new risk classification]Atsushi Wake, Kotaro Shirakawa, Masanori Kamio, et al.
Internal Medicine (Tokyo, Japan)|March 13, 2018
Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative DisorderYuji Eso, Norimitsu Uza, Kotaro Shirakawa, et al.
The Journal of Biological Chemistry|October 21, 2016
Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated DegradationYusuke Matsui, Keisuke Shindo, Kayoko Nagata, et al.
Current Biology : CB|August 8, 2006
Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanismsAierken Abudu, Akifumi Takaori-Kondo, Taisuke Izumi, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 3, 2025
[Recent advances in research of cure of HIV infection]Kotaro Shirakawa
Mini Reviews in Medicinal Chemistry|March 14, 2008
Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapyTaisuke Izumi, Kotaro Shirakawa, Akifumi Takaori-Kondo
Current Opinion in HIV and AIDS|January 19, 2011
Epigenetic regulation of HIV latencyShweta Hakre, Leonard Chavez, Kotaro Shirakawa, et al.
FEMS Microbiology Reviews|March 1, 2012
HIV latency: experimental systems and molecular modelsShweta Hakre, Leonard Chavez, Kotaro Shirakawa, et al.
Trends in Microbiology|March 23, 2013
Reactivation of latent HIV by histone deacetylase inhibitorsKotaro Shirakawa, Leonard Chavez, Shweta Hakre, et al.
Biochemical and Biophysical Research Communications|May 25, 2020
Critical role of PP2A-B56 family protein degradation in HIV-1 Vif mediated G2 cell cycle arrestKayoko Nagata, Keisuke Shindo, Yusuke Matsui, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2004
[Analyses of the allogeneic stem cell transplantation outcome based on the new risk classification]Atsushi Wake, Kotaro Shirakawa, Masanori Kamio, et al.
Internal Medicine (Tokyo, Japan)|March 13, 2018
Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative DisorderYuji Eso, Norimitsu Uza, Kotaro Shirakawa, et al.
The Journal of Biological Chemistry|October 21, 2016
Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated DegradationYusuke Matsui, Keisuke Shindo, Kayoko Nagata, et al.
Current Biology : CB|August 8, 2006
Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanismsAierken Abudu, Akifumi Takaori-Kondo, Taisuke Izumi, et al.
Pageof 7